NSE ScannerOpen the scanner

Nippon India Mutual Fund · Equity · Large Cap · Direct plan

Nippon India Large Cap Fund - Direct Plan - Growth

₹96.0377NAV on 30 Oct 2026Expense ratio 0.85%
29 Oct 2025NAV low 91.45 · high 106.13-9.2%

In plain words

Over 3 years it returned +11.0% a year, against +7.4% for its benchmark index.

Its worst fall from a peak in the last 3 years was -15.4%.

On 3-year return it ranks 8 of 30 funds in Large Cap.

A monthly SIP over 10 years ended ₹1,25,366 higher in the direct plan than the regular plan, because of the lower expense ratio.

Past returns, not a promise of future returns or a recommendation.

Returns vs benchmark

PeriodFundBenchmark
1 month+0.4%+1.9%
3 months-5.4%-5.1%
6 months-3.5%-3.2%
1 year-8.8%-10.2%
3 years (yearly)+11.0%+7.4%
5 years (yearly)+12.0%+6.5%
10 years (yearly)+13.7%+11.3%
Since start (yearly)+14.5%+11.2%

Monthly SIP of ₹10,000

PeriodInvestedValue nowYearly return
1 year₹1,20,000₹1,13,526-8.7%
3 years₹3,60,000₹3,70,093+1.7%
5 years₹5,90,000₹7,48,283+9.3%
10 years₹11,90,000₹24,35,220+13.7%

Top holdings (30 Sept 2026)

Fund size ₹51,296 crore · 69 holdings · 99.7% in equity

CompanyIndustryWeight
HDFC Bank LimitedBanks9.61%
ICICI Bank LimitedBanks6.09%
Axis Bank LimitedBanks5.26%
Reliance Industries LimitedPetroleum Products3.92%
Larsen & Toubro LimitedConstruction3.63%
Infosys LimitedIT - Software3.36%
Tata Consultancy Services LimitedIT - Software3.12%
Bajaj Finance LimitedFinance3.09%
State Bank of IndiaBanks2.82%
Hindustan Unilever LimitedDiversified FMCG2.74%
ITC LimitedDiversified FMCG2.56%
Mahindra & Mahindra LimitedAutomobiles2.49%
Avenue Supermarts LimitedRetailing2.46%
Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology2.18%
Kotak Mahindra Bank LimitedBanks2.03%

Largest industries: Banks 25.8%, Retailing 8.3%, IT - Software 8.3%, Pharmaceuticals & Biotechnology 7.5%, Diversified FMCG 5.3%, Finance 4.5%.

Other plan of this fund: Nippon India Large Cap Fund - Regular Plan - Growth

Share on WhatsAppShare on Telegram